CJC-1295 No DAC
hormonal compound
CJC-1295 No DAC is a synthetic analog of growth hormone-releasing hormone engineered to induce rapid, pulsatile secretion of endogenous growth hormone. It serves as a potent secretagogue that closely mirrors natural physiological GH release patterns.
Research Areas
Mechanism of Action
The peptide functions as a selective agonist at the GHRH receptor on pituitary somatotrophs, triggering a transient and concentrated release of endogenous growth hormone.
Biological Pathways
Areas of Research Interest
Potential effects under study. Not all are established in humans.
- •Stimulates pulsatile endogenous GH secretion
- •Enhances systemic recovery and repair
- •Promotes muscle protein synthesis and hypertrophy
- •Supports improved lipid metabolic profiles
Risks & Cautions
CJC-1295 No DAC is classified as higher complexity. This is a relative educational classification, not a determination of safety. Effects, adverse events and long-term data may be incomplete. Speak with a licensed healthcare professional about any individual decision.
Evidence & Research References
Research references are being reviewed for this entry.
STACKWELL classification: Moderate Evidence. Classifications are editorial and are never influenced by commercial relationships.
Frequently Asked Questions
Community Discussion
Questions and experiences from members. Community posts are anecdotes, not clinical evidence.
Discuss CJC-1295 No DACEducational content only. STACKWELL summarizes published research and does not provide individualized medical advice. Some compounds discussed may be investigational or not approved for human use in your jurisdiction. STACKWELL does not recommend, prescribe or dose any compound, and this content is not a substitute for care from a qualified healthcare professional.